OECOrion S.A.
Is the price fair?
Neither cheap nor expensive: modest expectations priced in, but at the top of its own P/E range.
Priced for a decline (~−0% a year). Little growth is priced in even as revenue fell 2% a year over three years, potential value, or a value trap.
Expensive vs its own history: P/E 38.5 vs a 13.2 median over 26 quarters (+191% vs median).
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What OEC's price assumes
Today's price asks for −0.22% free cash flow growth a year; over the last three years Orion S.A. delivered −44%, the price is ahead of the record.
Price / sales · no P/E: the last twelve months did not end in a profit
- Free cash flow yield
- 7.8%
Free cash flow yield · Specialty Chemicals median 4.7%
- Growth the price implies
- −0.22%
Growth the price implies · The price pays for −0.22% free cash flow growth a year for a decade; the business has delivered −44% a year over the last three.
- Price / book
- 0.96
Price / book · as of 2026-Q1
Details›
- Price / bookas of 2026-Q1
- 0.96
- EV / EBIToperating margin −0.17%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q1
- 0.74
- Free cash flow, trailing twelve months
- $26M
- Market capitalisation
- $328M
- 3-year revenue growth
- −2.5%
- 3-year free cash flow growth
- −44%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Specialty Chemicals
Ranks #23 of 33 by RyuScore